Ann Arbor, MINCT05733832Now EnrollingIRB Ready

Liver Diseases Clinical Trial in Ann Arbor, MI

Access cutting-edge liver diseases treatment through this clinical trial at a research site in Ann Arbor. Study-provided care at no cost to qualified participants.

Sponsored by Indiana University

Quick Self-Assessment

See if you qualify for this Ann Arbor location

Preparing your pre-screening questions…

Expert Care in Ann Arbor

Access liver diseases specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related liver diseases treatment provided free

Apply for This Ann Arbor Location

Check if you qualify for this liver diseases clinical trial in Ann Arbor, MI

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Ann Arbor

    Convenient for MI residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Ann Arbor site if eligible
  4. 4Begin participation

About This Liver Diseases Study in Ann Arbor

Patients with complications of advanced liver disease often have difficulties after hospital discharge that result in early hospital readmission. Poor outcomes for these patients during this transitional time could be improved through the use of innovative transitional care models. This proposal aims to examine the effect of a transitional care model, The Transitional Liver Clinic (TLC), in reducing hospital re-admissions, improving quality of life, and improving patient experience.

Sponsor: Indiana University

Who Can Participate

Inclusion Criteria

Male or female age ≥18
Diagnosis of advanced liver disease, defined as either (must meet either a or b)
cirrhosis based on (either i or ii):
characteristic clinical, laboratory, and imaging findings
acute alcoholic hepatitis, defined by NIAAA Alcoholic Hepatitis Consortia, as
onset of jaundice (serum bilirubin \>3.0 mg/dL) in prior 8 weeks
consumption of \>40 (female) or 60 (male) g alcohol/day for ≥6 months, with \<60 days abstinence before jaundice onset,
AST\>50 IU/L, AST/ALT\>1.5, and both values \<400 IU/L
liver biopsy confirmation in patients with confounding factors
Has at least one of the following complications due to advanced liver disease occurring during hospitalization:
ascites requiring diuretics or paracentesis
hepatic encephalopathy requiring lactulose or rifaximin
gastrointestinal bleeding due to portal hypertension
Has planned discharge alive to home or a facility within 72 hours of informed consent
Able and willing to provide informed consent

Exclusion Criteria

discharge under hospice
listed for liver transplant with MELD-Na ≥ 35
unable or unwilling to participate in post-discharge follow-up either in-person or virtually
unable to speak or understand English and/or Spanish
low hearing or communicative ability (examiner rated) that would interfere with interventions and outcome assessments
lack of access to a telephone
incarcerated
concurrent enrollment in an interventional research study

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Ann Arbor?

Yes, this clinical trial (NCT05733832) has an active research site in Ann Arbor, MI that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Liver Diseases Treatment Options in Ann Arbor, MI

If you're searching for liver diseases treatment options in Ann Arbor, MI, this clinical trial (NCT05733832) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Ann Arbor research site is actively enrolling participants for this clinical trial. You'll receive care from experienced liver diseases specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all liver diseases clinical trials near you to find additional studies recruiting in your area.

More Ankylosing Spondylitis Trials in Ann Arbor, MI

See all ankylosing spondylitis clinical trials recruiting in Ann Arbor — not just this study.

Browse Ankylosing Spondylitis Trials in Ann Arbor →

Browse More Trials by Condition

Ankylosing Spondylitis TrialsLiver Disease TrialsAll Conditions →

Ready to Join in Ann Arbor?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Ann Arbor, MI